Thu, Nov 12, 2026 - Page 65
13819 indexed SquawkNews stories from this UTC day. Showing 7681-7800.
M
Kraft Heinz Sees FY2027 Adjusted Operating Income Declining Low Single Digits
The company expects adjusted operating income to decline by low single digits versus 2026, with a return to growth in the second half of 2027.
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
ALTIMMUNE Q3 EPS USD -0.15 VS. IBES ESTIMATE USD -0.14
ALTIMMUNE Q3 EPS USD -0.15 VS. IBES ESTIMATE USD -0.14
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
SUBURBAN PROPANE PARTNERS Q4 REVENUE USD 219.864 MILLION
SUBURBAN PROPANE PARTNERS Q4 REVENUE USD 219.864 MILLION
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
TAYSHA GENE THERAPIES Q3 EPS USD -0.1
TAYSHA GENE THERAPIES Q3 EPS USD -0.1
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
SOLO BRANDS Q3 GROSS PROFIT USD 27.716 MILLION
SOLO BRANDS Q3 GROSS PROFIT USD 27.716 MILLION
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
SOLO BRANDS Q3 ADJUSTED EPS USD -4.51
SOLO BRANDS Q3 ADJUSTED EPS USD -4.51
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Recently announced acquisition of assets of Heron Therapeutics — — Q3 2026 consolidated revenue of
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
CORMEDIX THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
CORMEDIX THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
TAYSHA GENE THERAPIES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
TAYSHA GENE THERAPIES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
SOLO BRANDS Q3 NET INCOME USD -20.754 MILLION
SOLO BRANDS Q3 NET INCOME USD -20.754 MILLION
FX | Nov 12, 2026, 12:30 PM UTC
L
Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update — Re
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
Boost Run (BRUN) Q3 Revenue Reaches $39.9M, Up Approximately 496% YoY
Boost Run reported Q3 2026 revenue of $39.9M, approximately 496% higher year over year. It reported $157M in unrestricted cash at quarter-end and $2.7B in total contract value.Material DetailsContext by AI AnalystThis is
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
SUBURBAN PROPANE PARTNERS Q4 PRETAX PROFIT USD -55.106 MILLION
SUBURBAN PROPANE PARTNERS Q4 PRETAX PROFIT USD -55.106 MILLION
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
CORMEDIX Q3 EPS USD -0.19 VS. IBES ESTIMATE USD -0.12
CORMEDIX Q3 EPS USD -0.19 VS. IBES ESTIMATE USD -0.12
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
TAYSHA GENE THERAPIES Q3 OPERATING INCOME USD -41.872 MILLION
TAYSHA GENE THERAPIES Q3 OPERATING INCOME USD -41.872 MILLION
FX | Nov 12, 2026, 12:30 PM UTC
L
Treaty Creek Drill Intersects 9.00 g/t Gold Over 9.50 Metres
Teuton Resources reports drilling at the Treaty Creek property intersected 9.00 g/t gold over 9.50 metres, including 43.29 g/t over 1.20 metres.
COMMODITIES | Nov 12, 2026, 12:30 PM UTC
L
Nexxen International 3Q EPS 32c >NEXN
Nexxen International 3Q EPS 32c >NEXN
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
Creative Realities Signs Exclusive Agreement With Toyota/Lexus Canada
Creative Realities announced an exclusive agreement with Toyota/Lexus Canada to power the dealership digital experience.
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
Altimmune Announces Third Quarter 2026 Financial Results and Business Update
Altimmune Announces Third Quarter 2026 Financial Results and Business Update Global PERFORMA Phase 3
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
NEUPATH HEALTH Q3 ADJUSTED EBITDA CAD 200 THOUSAND
NEUPATH HEALTH Q3 ADJUSTED EBITDA CAD 200 THOUSAND
FX | Nov 12, 2026, 12:30 PM UTC
L
NeuPath Health Inc. (NPTH) Q3 Revenue Rises 1% to $22.3M; Adjusted EBITDA Falls to $1.4M
Q3 2026 revenue was $22.3M versus $22.1M a year earlier; Adjusted EBITDA was $1.4M versus $1.5M. Nine-month revenue was $67.1M versus $65.0M, including a $1.9M prior-year one-time payment; excluding it, prior-year revenu
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
ALTIMMUNE ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS UPDATE
ALTIMMUNE ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS UPDATE
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update REV
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
SOLO BRANDS, INC. ANNOUNCES FISCAL 2026 THIRD QUARTER RESULTS
SOLO BRANDS, INC. ANNOUNCES FISCAL 2026 THIRD QUARTER RESULTS
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
Nexxen International 3Q Rev $102.9M >NEXN
Nexxen International 3Q Rev $102.9M >NEXN
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
SUBURBAN PROPANE PARTNERS, L.P. ANNOUNCES FULL YEAR AND FOURTH QUARTER RESULTS
SUBURBAN PROPANE PARTNERS, L.P. ANNOUNCES FULL YEAR AND FOURTH QUARTER RESULTS
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
AVICANNA REPORTS POSITIVE ADJUSTED EBITDA FOR Q3 2026 AND PROVIDES CORPORATE UPDATE
AVICANNA REPORTS POSITIVE ADJUSTED EBITDA FOR Q3 2026 AND PROVIDES CORPORATE UPDATE
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
BASE CARBON REPORTS THIRD-QUARTER 2026 OPERATING AND FINANCIAL RESULTS
BASE CARBON REPORTS THIRD-QUARTER 2026 OPERATING AND FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
ASCENDIS PHARMA REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
ASCENDIS PHARMA REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18% Sequential Revenue Growth
Net Income was positive for the second consecutive quarter, and Adjusted EBITDA1 positive for its th
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
Nexxen Reports Record Third Quarter 2026 Financial Results
Nexxen Reports Record Third Quarter 2026 Financial Results Delivered record Q3 Contribution ex-TAC a
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
ALTIMMUNE Q3 BASIC EPS USD -0.15
ALTIMMUNE Q3 BASIC EPS USD -0.15
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
SUBURBAN PROPANE PARTNERS Q4 OPERATING INCOME USD -12.909 MILLION
SUBURBAN PROPANE PARTNERS Q4 OPERATING INCOME USD -12.909 MILLION
FX | Nov 12, 2026, 12:30 PM UTC
L
Ascendis Pharma Reports Third Quarter 2026 Financial Results
Ascendis Pharma Reports Third Quarter 2026 Financial Results Q3 2026 product revenue of €366 million
EARNINGS | Nov 12, 2026, 12:30 PM UTC
M
Boost Run Reports Third-Quarter 2026 Results
Boost Run reported third-quarter results, highlighting $2.7 billion in total contract value and 496% year-over-year revenue growth.
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
ALTIMMUNE Q3 NET INCOME USD -31.608 MILLION VS. IBES ESTIMATE USD -25.5 MILLION
ALTIMMUNE Q3 NET INCOME USD -31.608 MILLION VS. IBES ESTIMATE USD -25.5 MILLION
FX | Nov 12, 2026, 12:30 PM UTC
L
SUBURBAN PROPANE PARTNERS Q4 NET INCOME USD -56.841 MILLION
SUBURBAN PROPANE PARTNERS Q4 NET INCOME USD -56.841 MILLION
FX | Nov 12, 2026, 12:30 PM UTC
L
NEXXEN REPORTS RECORD THIRD QUARTER 2026 FINANCIAL RESULTS
NEXXEN REPORTS RECORD THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
BRIDGEMARQ Q3 NET INCOME CAD 66.9 MILLION
BRIDGEMARQ Q3 NET INCOME CAD 66.9 MILLION
FX | Nov 12, 2026, 12:30 PM UTC
L
Creative Realities Signs Exclusive Agreement With Toyota and Lexus Canada
Creative Realities signed an exclusive agreement with Toyota and Lexus Canada to power the dealership digital experience.
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
AVICANNA Q3 REVENUE CAD 5.73 MILLION
AVICANNA Q3 REVENUE CAD 5.73 MILLION
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
BRIDGEMARQ Q3 EPS CAD 0.04
BRIDGEMARQ Q3 EPS CAD 0.04
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
Suburban Propane Partners, L.P. Announces Full Year and Fourth Quarter Results
WHIPPANY, N.J., Nov. 12, 2026 /PRNewswire/ -- Suburban Propane Partners, L.P.
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
Solo Brands, Inc. Announces Fiscal 2026 Third Quarter Results
Solo Brands, Inc. Announces Fiscal 2026 Third Quarter Results Positive Operating Cash Flow and Impro
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
BRIDGEMARQ REAL ESTATE SERVICES® REPORTS THIRD QUARTER FINANCIAL RESULTS
BRIDGEMARQ REAL ESTATE SERVICES® REPORTS THIRD QUARTER FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
MEDIPHARM LABS Q3 REVENUE CAD 11.8 MILLION
MEDIPHARM LABS Q3 REVENUE CAD 11.8 MILLION
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
MEDIPHARM LABS Q3 ADJUSTED EBITDA CAD 400 THOUSAND
MEDIPHARM LABS Q3 ADJUSTED EBITDA CAD 400 THOUSAND
FX | Nov 12, 2026, 12:30 PM UTC
L
MEDIPHARM LABS Q3 GROSS PROFIT CAD 3.8 MILLION
MEDIPHARM LABS Q3 GROSS PROFIT CAD 3.8 MILLION
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
CorMedix 3Q Loss/Shr 19c >CRMD
CorMedix 3Q Loss/Shr 19c >CRMD
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
SAGIMET BIOSCIENCES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES
SAGIMET BIOSCIENCES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
Ascendis Pharma Reports Third Quarter 2026 Financial Results
Q3 2026 product revenue of €366 million (+89% Y/Y), comprising €291 million for YORVIPATH®, €59 mill
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
NEUPATH HEALTH REPORTS THIRD QUARTER 2026 RESULTS
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), which operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic p
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
BOOST RUN INC. REPORTS THIRD QUARTER 2026 RESULTS, HIGHLIGHTING $2.7 BILLION IN TOTAL CONTRACT VALUE AND 496% YEAR-OVER-YEAR REVENUE GROWTH
BOOST RUN INC. REPORTS THIRD QUARTER 2026 RESULTS, HIGHLIGHTING $2.7 BILLION IN TOTAL CONTRACT VALUE
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
BRIDGEMARQ Q3 OPERATING CASH FLOW CAD 6.012 MILLION
BRIDGEMARQ Q3 OPERATING CASH FLOW CAD 6.012 MILLION
FX | Nov 12, 2026, 12:30 PM UTC
L
BRIDGEMARQ Q3 REVENUE CAD 107.728 MILLION
BRIDGEMARQ Q3 REVENUE CAD 107.728 MILLION
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
NEUPATH HEALTH Q3 REVENUE CAD 22.3 MILLION
NEUPATH HEALTH Q3 REVENUE CAD 22.3 MILLION
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
MEDIPHARM LABS REPORTS Q3 2026 RESULTS WITH SECOND CONSECUTIVE QUARTER OF POSITIVE NET INCOME AND 18% SEQUENTIAL REVENUE GROWTH
MEDIPHARM LABS REPORTS Q3 2026 RESULTS WITH SECOND CONSECUTIVE QUARTER OF POSITIVE NET INCOME AND 18
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
Base Carbon Reports Third-Quarter 2026 Operating and Financial Results
Base Carbon Reports Third-Quarter 2026 Operating and Financial Results TORONTO, Nov. 12, 2026 (GLOBE
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
NEUPATH HEALTH REPORTS THIRD QUARTER 2026 RESULTS
NEUPATH HEALTH REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
Taysha Gene Therapies 3Q Loss/Shr 10c >TSHA
Taysha Gene Therapies 3Q Loss/Shr 10c >TSHA
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18% Sequential Revenue Growth
MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
Taysha Gene Therapies 3Q Loss $39.1M >TSHA
Taysha Gene Therapies 3Q Loss $39.1M >TSHA
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
SAGIMET BIOSCIENCES Q3 NET INCOME USD -19.149 MILLION
SAGIMET BIOSCIENCES Q3 NET INCOME USD -19.149 MILLION
FX | Nov 12, 2026, 12:30 PM UTC
L
Avicanna Reports Positive Adjusted EBITDA for Q3 2026 and Provides Corporate Update
Avicanna Reports Positive Adjusted EBITDA for Q3 2026 and Provides Corporate Update Adjusted EBITDA
EQUITY | Nov 12, 2026, 12:30 PM UTC
M
European session market picture: S&P 500 -0.38%, Nasdaq 100 -0.86%; EUR/USD +0.01%, WTI -0.86%, LLOY leads volume
European session market picture. US index futures: S and P futures is down 0.38 percent, Nasdaq futures is down 0.86 percent, Dow futures is up 0.11 percent and Russell futures is down 0.08 percent. In currencies, the do
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
NEUPATH HEALTH REPORTS THIRD QUARTER 2026 RESULTS
Third quarter total revenue of $22.3 million Positive cash flows from operations, with Adjusted EBIT
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
Altimmune 3Q Loss/Shr 15c >ALT
Altimmune 3Q Loss/Shr 15c >ALT
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
Boost Run Inc. Reports Third Quarter 2026 Results, Highlighting $2.7 Billion in Total Contract Value and 496% Year-Over-Year Revenue Growth
NORTHBROOK, Ill.--(BUSINESS WIRE)-- Boost Run, Inc. (Nasdaq: BRUN), an NVIDIA Preferred Cloud Partne
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
Suburban Propane 4Q Rev $219.9M >SPH
Suburban Propane 4Q Rev $219.9M >SPH
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
Suburban Propane 4Q Loss $56.8M >SPH
Suburban Propane 4Q Loss $56.8M >SPH
EQUITY | Nov 12, 2026, 12:30 PM UTC
H
*--Earnings Flash (GENB) Generate Biomedicines Posts Q3 Net Loss $0.68 a Share, vs. FactSet Est of $0.56 Loss
*--Earnings Flash (GENB) Generate Biomedicines Posts Q3 Net Loss $0.68 a Share, vs. FactSet Est of $0.56 Loss
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
Nexxen Reports Record Third Quarter 2026 Financial Results
Delivered record Q3 Contribution ex-TAC and programmatic revenue, highlighted by continued enterpris
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
Suburban Propane 4Q Loss/Shr 85c >SPH
Suburban Propane 4Q Loss/Shr 85c >SPH
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
Creative Realities Signs Exclusive Toyota/Lexus Canada Dealership Agreement
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
Bridgemarq Real Estate Services® Reports Third Quarter Financial Results
TORONTO, Nov. 12, 2026 /CNW/ -- Bridgemarq Real Estate Services Inc.
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
Bridgemarq Real Estate 3Q EPS C$0.04 >BRE.T
Bridgemarq Real Estate 3Q EPS C$0.04 >BRE.T
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates Regi
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
Takeda Launches Narcolepsy Pill in US After DEA Clearance
Takeda said its narcolepsy pill, Orzeyful, is now available in the US after a Drug Enforcement Administration decision removed the final regulatory hurdle to its rollout.
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
GENERATE BIOMEDICINES INC - Q3 EPS $-0.68
GENERATE BIOMEDICINES INC - Q3 EPS $-0.68
EARNINGS | Nov 12, 2026, 12:29 PM UTC
M
Sweden’s Bunge Says Recovery and Inflation Support Tighter Policy
Deputy Governor Aino Bunge said Sweden’s economy is recovering broadly and inflation is expected to rise above target next year.
CENTRAL_BANK | Nov 12, 2026, 12:29 PM UTC
L
Ukraine Seeks Details From US on Starshield Restrictions
Ukraine is seeking details from the United States about restrictions on Starshield.
EQUITY | Nov 12, 2026, 12:29 PM UTC
L
Codere Online Q3 net income more than triples to EUR 5.5 million
Codere Online Q3 net income more than triples to EUR 5.5 million Codere Online’s third-quarter 2
FX | Nov 12, 2026, 12:29 PM UTC
L
Barclays raises Alcon target price to $80 from $70
EQUITY | Nov 12, 2026, 12:29 PM UTC
L
Lithium Americas Cuts FY Tariff Exposure Estimate to About $60 Million
EQUITY | Nov 12, 2026, 12:29 PM UTC
H
*--Earnings Flash (ARCO) Arcos Dorados Posts Q3 EPS $0.15, vs. FactSet Est of $0.14
*--Earnings Flash (ARCO) Arcos Dorados Posts Q3 EPS $0.15, vs. FactSet Est of $0.14
EARNINGS | Nov 12, 2026, 12:29 PM UTC
L
MediWound Q3 net loss more than doubles to $5.99 million; Q3 revenue falls 34% to $3.57 million
MediWound Q3 net loss more than doubles to $5.99 million; Q3 revenue falls 34% to $3.57 million
EARNINGS | Nov 12, 2026, 12:29 PM UTC
L
Cascade Copper Confirms Historic High-Grade Drill Results at Copper Plateau
Cascade Copper confirmed historic high-grade drill results at its Copper Plateau project. The report provides no grades or other drill-result details.
EQUITY | Nov 12, 2026, 12:29 PM UTC
L
Correct: Hudbay Minerals 3Q EPS $0.34 >HBM.T
Correct: Hudbay Minerals 3Q EPS $0.34 >HBM.T
EARNINGS | Nov 12, 2026, 12:29 PM UTC
M
UK GDP Growth Prompts Higher December BOE Rate Expectations
UK annual GDP expanded 2.1% in September, above the 1.9% expected by economists in a WSJ poll, lifting expectations for a BOE rate increase at its December meeting.
MACRO | Nov 12, 2026, 12:29 PM UTC
L
Abu Dhabi Ship Building Q3 Profit 46.6 Mln Dirhams
ABU DHABI SHIP BUILDING ADX:ADSB
EARNINGS | Nov 12, 2026, 12:29 PM UTC
M
Brookfield Q3 Revenue Rises 9%, EPS Climbs
EQUITY | Nov 12, 2026, 12:29 PM UTC
M
Aya Gold & Silver Q3-2026 net income more than doubles YoY to $35.01 million
Aya Gold & Silver Q3-2026 net income more than doubles YoY to $35.01 million Aya Gold & Silver’s
COMMODITIES | Nov 12, 2026, 12:29 PM UTC
L
Crypto-Linked Stocks Dip as MSCI Removes Strategy From Indices
Crypto-linked stocks dipped after MSCI said it will remove Strategy from its indices.
EQUITY | Nov 12, 2026, 12:29 PM UTC
L
BRIEF-Abu Dhabi Ship Building Q3 Profit 46.6 Mln Dirhams
BRIEF-Abu Dhabi Ship Building Q3 Profit 46.6 Mln Dirhams Nov 12 (Reuters) - ABU DHABI SHIP BUILDING
EARNINGS | Nov 12, 2026, 12:29 PM UTC
L
Brookfield Q3 revenue rises 9%, EPS climbs
Brookfield Q3 revenue rises 9%, EPS climbs Overview Global investment firm's Q3 revenue rose 9% yr/y
EARNINGS | Nov 12, 2026, 12:29 PM UTC
L
SOFTS-Raw sugar heads back towards 5-week low as energy prices weaken
SOFTS-Raw sugar heads back towards 5-week low as energy prices weaken LONDON, Nov 12 (Reuters) - Raw
EQUITY | Nov 12, 2026, 12:28 PM UTC
L
Correct: Hudbay Minerals 3Q Rev $765.9M >HBM.T
Correct: Hudbay Minerals 3Q Rev $765.9M >HBM.T
EQUITY | Nov 12, 2026, 12:28 PM UTC
L
SAMSONITE GROUP SA Q3 NET INCOME ATTRIBUTABLE USD 58.1 MILLION
SAMSONITE GROUP SA Q3 NET INCOME ATTRIBUTABLE USD 58.1 MILLION
FX | Nov 12, 2026, 12:28 PM UTC
L
HYPERION DEFI Q3 EPS USD 1.23
HYPERION DEFI Q3 EPS USD 1.23
EARNINGS | Nov 12, 2026, 12:28 PM UTC
L
ADI Global Distribution Swings to Q3 2026 Net Loss of $655 Million
ADI Global Distribution Swings to Q3 2026 Net Loss of $655 Million ADI Global Distribution swung
EQUITY | Nov 12, 2026, 12:28 PM UTC
L
GENERATE BIOMEDICINES - Q3 REVENUE $4.20 MLN
GENERATE BIOMEDICINES - Q3 REVENUE $4.20 MLN
EARNINGS | Nov 12, 2026, 12:28 PM UTC
L
Osisko Gold Names Elijah Tyshynski CFO
Elijah Tyshynski will succeed Alexander Dann as CFO of Osisko Gold.
EQUITY | Nov 12, 2026, 12:28 PM UTC
L
Bahrain's Sico Q3 Profit 544,000 Dinars
SICO BAHRAIN:SICO-C
EARNINGS | Nov 12, 2026, 12:28 PM UTC
L
BRIEF-Bahrain's Sico Q3 Profit 544,000 Dinars
BRIEF-Bahrain's Sico Q3 Profit 544,000 Dinars Nov 12 (Reuters) - SICO SICO.BH: Q3 PROFIT 544,000 DIN
EARNINGS | Nov 12, 2026, 12:28 PM UTC
H
Poste Italiane earnings below expectations at 0.46 EUR
Poste Italiane (PST) released earnings per share at 0.46 EUR, compared to market expectations of 0.53 EUR.
EARNINGS | Nov 12, 2026, 12:28 PM UTC
L
Nouveau Monde Graphite Adds Eni Representative to Board
Nouveau Monde Graphite added an Eni representative to its board.
EQUITY | Nov 12, 2026, 12:28 PM UTC
L
SAMSONITE GROUP SA Q3 SALES USD 872.7 MILLION
SAMSONITE GROUP SA Q3 SALES USD 872.7 MILLION
FX | Nov 12, 2026, 12:28 PM UTC
M
Lithium Americas targets Thacker Pass Phase 1 capex of $1.7B-$2B for FY2026
EARNINGS | Nov 12, 2026, 12:27 PM UTC
M
Ukraine Peace Talks Between Putin and US Envoys Start in Moscow
Reuters reports that Ukraine peace talks between Putin and US envoys have started in Moscow.
GEOPOLITICS | Nov 12, 2026, 12:27 PM UTC
M
MSCI to Remove Strategy From Global Equity Benchmarks
MSCI will remove Strategy from its global equity benchmarks, including the MSCI USA index, at month-end. The report also says investors are dumping a chunk of the company’s stock.
EQUITY | Nov 12, 2026, 12:27 PM UTC
L
CORRECTED-ARCOS DORADOS Q3 REVENUE USD 1,328 MILLION VS. IBES ESTIMATE USD 1,320 MILLION (CORRECTS AMOUNT)
CORRECTED-ARCOS DORADOS Q3 REVENUE USD 1,328 MILLION VS. IBES ESTIMATE USD 1,320 MILLION (CORRECTS A
EARNINGS | Nov 12, 2026, 12:27 PM UTC
M
SOLV Energy Q3 Revenue Rose 65% to $1.2B, Raises 2026 Guidance
Q3 2026 net income was $123 million, versus $70 million a year earlier. Updated full-year guidance figures were not provided.
EQUITY | Nov 12, 2026, 12:27 PM UTC
L
Generate Biomedicines (GENB) Reports $87.7M Q3 Net Loss; Cash Runway Into H1 2028
Generate Biomedicines reported Q3 2026 net loss of $87.7M versus $60.0M in Q3 2025. Cash, equivalents and marketable securities were $404.2M at Sept. 30, compared with $457.4M at June 30; the company expects funding into
EQUITY | Nov 12, 2026, 12:27 PM UTC
M
TSX Futures Edge Down as AI Sentiment Weakens; Oil, Gold Fall
Canadian stock futures edged lower amid weaker AI sentiment, while oil and gold also declined.
EQUITY | Nov 12, 2026, 12:27 PM UTC
L
Petrobras Net Debt Falls 4.2% to USD 57.85 Billion in Third Quarter
Petrobras Net Debt Falls 4.2% to USD 57.85 Billion in Third Quarter Petrobras’ total assets rose
FX | Nov 12, 2026, 12:27 PM UTC
H
*--Earnings Flash (AYA) Aya Gold & Silver Posts Q3 EPS $0.22
*--Earnings Flash (AYA) Aya Gold & Silver Posts Q3 EPS $0.22
EARNINGS | Nov 12, 2026, 12:26 PM UTC
L
BK Technologies Q3 revenue rises on strong federal demand
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 12:26 PM UTC
M
OSISKO GOLD GROUP: Q3 2026 REVENUES $19.3MLN FROM TINTIC PROJECT TEST MINING
OSISKO GOLD GROUP: Q3 2026 REVENUES $19.3MLN FROM TINTIC PROJECT TEST MINING
COMMODITIES | Nov 12, 2026, 12:26 PM UTC
L
BK Technologies Q3 revenue rises on strong federal demand
BK Technologies Q3 revenue rises on strong federal demand Overview US public safety radio maker's fi
EARNINGS | Nov 12, 2026, 12:26 PM UTC
L
CORRECTED-BK TECHNOLOGIES CORP Q3 GROSS MARGIN 50.7% (CORRECTS AMOUNT)
CORRECTED-BK TECHNOLOGIES CORP Q3 GROSS MARGIN 50.7% (CORRECTS AMOUNT)
EQUITY | Nov 12, 2026, 12:26 PM UTC